1. 632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers' Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD). (31st December 2020) Authors: Gutierrez, Ramiro L; Burns, Daniel; Lalani, Tahaniyat; Bennett-Carter, Denise; Fraser, Jamie; Riddle, Mark; Connor, Patrick; Porter, Chad; Troth, Thomas; Ruck, Richard; Barton, Jerry; Tilley, Drake H; Kunz, Anjali; Fairchok, Mary; Yun, Heather; Alvarez, Bryan; Higgins, Robert; Mitra, Indrani; Ste... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗